Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus.
Conti DM, Vibeke B, Kirsten B, Leif B, Adam C, Stephanie D, Mina G, Monika G, Philippe G, Eckard H, Hellings PW, Milos J, Kopp MV, Marcus M, Marcia P, Dermot R, Scadding GK, Eike W, Ulrich W, Susanne L. Conti DM, et al. Among authors: kopp mv. Pediatr Allergy Immunol. 2024 Jul;35(7):e14183. doi: 10.1111/pai.14183. Pediatr Allergy Immunol. 2024. PMID: 38949196 Free article.
Use of complementary and alternative medicine in children with asthma.
Ricklefs I, Hohmann-Ebbers M, Herz A, Kopp MV. Ricklefs I, et al. Among authors: kopp mv. Pediatr Allergy Immunol. 2018 May;29(3):326-328. doi: 10.1111/pai.12863. Epub 2018 Feb 25. Pediatr Allergy Immunol. 2018. PMID: 29336063 No abstract available.
Perspectives in allergen immunotherapy: 2019 and beyond.
Pfaar O, Agache I, de Blay F, Bonini S, Chaker AM, Durham SR, Gawlik R, Hellings PW, Jutel M, Kleine-Tebbe J, Klimek L, Kopp MV, Nandy A, Rabin RL, van Ree R, Renz H, Roberts G, Salapatek AM, Schmidt-Weber CB, Shamji MH, Sturm GJ, Virchow JC, Wahn U, Willers C, Zieglmayer P, Akdis CA. Pfaar O, et al. Among authors: kopp mv. Allergy. 2019 Dec;74 Suppl 108:3-25. doi: 10.1111/all.14077. Allergy. 2019. PMID: 31872476 Review.
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement.
Calderon MA, Gerth van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, Eng P, Niggemann B, Nieto A, Valovirta E, Eigenmann PA, Pajno G, Bufe A, Halken S, Beyer K, Wahn U; European Academy of Allergy and Clinical Immunology. Calderon MA, et al. Among authors: kopp mv. Pediatr Allergy Immunol. 2012 Jun;23(4):300-6. doi: 10.1111/j.1399-3038.2012.01313.x. Pediatr Allergy Immunol. 2012. PMID: 22594930 Review.
Epigenetic training of human bronchial epithelium cells by repeated rhinovirus infections.
Risha MA, Reddy KD, Nemani SSP, Jakwerth C, Schmidt-Weber C, Bahmer T, Hansen G, von Mutius E, Rabe KF, Dittrich AM, Grychtol R, Maison N, Schaub B, Kopp MV, Brinkmann F, Meiners S, Jappe U, Weckmann M; ALLIANCE Study Group as part of the German Centre for Lung Research (DZL). Risha MA, et al. Among authors: kopp mv. Allergy. 2024 Dec;79(12):3385-3400. doi: 10.1111/all.16388. Epub 2024 Nov 8. Allergy. 2024. PMID: 39513674 Free PMC article.
A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. Rolinck-Werninghaus C, et al. Among authors: kopp mv. Allergy. 2004 Dec;59(12):1285-93. doi: 10.1111/j.1398-9995.2004.00627.x. Allergy. 2004. PMID: 15507097 Clinical Trial.
Perspectives in allergen immunotherapy: 2017 and beyond.
Pfaar O, Bonini S, Cardona V, Demoly P, Jakob T, Jutel M, Kleine-Tebbe J, Klimek L, Klysner S, Kopp MV, Kuna P, Larché M, Muraro A, Schmidt-Weber CB, Shamji MH, Simonsen K, Somoza C, Valovirta E, Zieglmayer P, Zuberbier T, Wahn U; FASIT group. Pfaar O, et al. Among authors: kopp mv. Allergy. 2018 Jan;73 Suppl 104:5-23. doi: 10.1111/all.13355. Allergy. 2018. PMID: 29171712 Free article. Review.
RNA-seq-based profiling of extracellular vesicles in plasma reveals a potential role of miR-122-5p in asthma.
Bahmer T, Krauss-Etschmann S, Buschmann D, Behrends J, Watz H, Kirsten AM, Pedersen F, Waschki B, Fuchs O, Pfaffl MW, von Mutius E, Rabe KF, Hansen G, Kopp MV, König IR, Bartel S. Bahmer T, et al. Among authors: kopp mv. Allergy. 2021 Jan;76(1):366-371. doi: 10.1111/all.14486. Epub 2020 Jul 17. Allergy. 2021. PMID: 32627209 Free PMC article. No abstract available.
Accelerated Dose Escalation with 3 Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of 6 Grasses Is Safe for Children and Adolescents with Moderate to Severe Allergic Rhinitis.
Bovermann X, Ricklefs I, Vogelberg C, Klimek L, Kopp MV. Bovermann X, et al. Among authors: kopp mv. Int Arch Allergy Immunol. 2021;182(6):524-534. doi: 10.1159/000512561. Epub 2021 Jan 27. Int Arch Allergy Immunol. 2021. PMID: 33503610 Free article. Clinical Trial.
126 results